G M De Ferrari

G M De Ferrari

Group Members

Gaetano M De Ferrari
(Head of Laboratory)

Sergio Leonardi    ,
(Clinical Scientist)

Diego Rizzotti     
(Postgraduate Fellow)

Marta Arpellini    
(Postgraduate Fellow)

Florinda Maiorana
(Postgraduate Fellow)

Arianna Bagnulo
(Research Nurse)

Antonio Sanzo
(Consultant)

Roberto Rordorf
(Consultant)

Gabriele Crimi
(Consultant)

Marcello Marino    
(Postdoctoral Fellow)

Veronica Dusi
(Clinical Fellow)

Claudia Pavesi
(Clinical Fellow)

Alessandra Greco
(Clinical Fellow)

Andrea Baldo
(Clinical Fellow)

Riccardo Maj
(Clinical Fellow)

Andrea Demarchi
(Clinical Fellow)

Stefano Cornara    
(Clinical Fellow)

Raniero Covi
(Clinical Fellow)

Alberto Somaschini
(Clinical Fellow)

Alessandro Mandurino Mirizzi
(Clinical Fellow)

 

Cardiovascular Clinical Research

The focus of our group is on clinical research. The Head of Laboratory has founded and directs the Cardiovascular Clinical Research Center that coordinates at local and national level several pharmacological clinical trials in the area of ischemic heart disease, heart failure and arrhythmias.  This activity includes collaboration with major research centers in Europe and the United States.

Additionally, the group is deeply involved in the development of new strategies to accomplish neuromodulation as a therapeutic approach for patients with advanced heart failure and with drug-refractory life-threatening arrhythmias. Specifically, this has included activities such as performing the first cases ever of vagus nerve stimulation in patients with cardiac disease and coordinating the registry on left cardiac sympathetic denervation for patients with catecholaminergic polymorphic ventricular tachycardia, a disease causing recurrent cardiac arrest in young and otherwise healthy individuals.

 

Selected Papers

de_ferrari2

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation. De Ferrari GM, Dusi V, Spazzolini C, et al.  Circulation. 131 (25):2185-93 (2015). doi: 10.1161/CIRCULATIONAHA.115.015731.

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.  De Ferrari GM, Maier LS, Mont L, et al.  Heart Rhythm. 12 (5):872-8 ((2015). doi: 10.1016/j.hrthm.2015.01.021.

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. CardioFit Multicenter Trial Investigators. De Ferrari GM, Crijns HJ, Borggrefe M, et al.  Eur Heart J. 32 (7):847-55 (2011). doi: 10.1093/eurheartj/ehq391.

Log In

Create an account